HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of PI3Kα and sarcolemmal ATP-sensitive potassium channels in epoxyeicosatrienoic acid mediated cardioprotection.

AbstractAIMS:
Epoxyeicosatrienoic acids (EETs) are cytochrome P450 epoxygenase metabolites of arachidonic acid that have known cardioprotective properties. While the mechanism(s) remains unknown, evidence suggests that phosphoinositide 3-kinase (PI3K) and sarcolemmal ATP-sensitive potassium channels (pmK(ATP)) are important. However the role of specific PI3K isoforms and corresponding intracellular mechanisms remains unknown.
METHODS AND RESULTS:
To study this, mice hearts were perfused in Langendorff mode for 40 min of baseline and subjected to 20 or 30 min of global no-flow ischemia followed by 40 min of reperfusion. C57BL6 mice perfused with 11,12-EET (1 μM) had improved postischemic recovery, whereas co-perfusion with PI3Kα inhibitor, PI-103 (0.1 μM), abolished the EET-mediated effect. In contrast, blocking of PI3Kβ or PI3Kγ isoforms failed to inhibit EET-mediated cardioprotection. In addition to the improved post-ischemic recovery, increased levels of p-Akt, decreased calcineurin activity and decreased translocation of proapoptotic protein BAD to mitochondria were noted in EET-treated hearts. Perfusion of 11,12-EET to Kir6.2 deficient mice (pmK(ATP)) failed to improve postischemic recovery, decrease calcineurin activity and translocation of proapoptotic protein BAD, however increased levels of p-Akt were still observed. Patch-clamp experiments demonstrated that 11,12-EET could not activate pmK(ATP) currents in myocytes pre-treated with PI-103. Mechanistic studies in H9c2 cells demonstrate that 11,12-EET limits anoxia-reoxygenation triggered Ca(2+) accumulation and maintains mitochondrial ΔΨm compared to controls. Both PI-103 and glibenclamide (10 μM, pmK(ATP) inhibitor) abolished EET cytoprotection.
CONCLUSION:
Together our data suggest that EET-mediated cardioprotection involves activation of PI3Kα, upstream of pmK(ATP), which prevents Ca(2+) overload and maintains mitochondrial function.
AuthorsSri N Batchu, Ketul R Chaudhary, Haitham El-Sikhry, Wei Yang, Peter E Light, Gavin Y Oudit, John M Seubert
JournalJournal of molecular and cellular cardiology (J Mol Cell Cardiol) Vol. 53 Issue 1 Pg. 43-52 (Jul 2012) ISSN: 1095-8584 [Electronic] England
PMID22561102 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier Ltd. All rights reserved.
Chemical References
  • Cardiotonic Agents
  • Isoenzymes
  • KATP Channels
  • 11,12-epoxy-5,8,14-eicosatrienoic acid
  • Class Ia Phosphatidylinositol 3-Kinase
  • 8,11,14-Eicosatrienoic Acid
  • Calcium
Topics
  • 8,11,14-Eicosatrienoic Acid (analogs & derivatives, pharmacology)
  • Animals
  • Calcium (metabolism)
  • Cardiotonic Agents (pharmacology)
  • Cell Line
  • Class Ia Phosphatidylinositol 3-Kinase (metabolism)
  • Heart (drug effects)
  • Hypoxia
  • Isoenzymes (metabolism)
  • KATP Channels (metabolism)
  • Membrane Potential, Mitochondrial (drug effects)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Myocardial Reperfusion Injury (metabolism, physiopathology, prevention & control)
  • Myocardium (enzymology, metabolism)
  • Sarcolemma (enzymology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: